VRS
IMVT icon

Virginia Retirement Systems’s Immunovant IMVT Stock Holding History

Virginia Retirement Systems’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,000
Closed -$295K – 1032
2023
Q1 		$295K Sell
19,000
-52,200
-73% -$906K ﹤0.01% 882
2022
Q4 		$1.26M Sell
71,200
-37,600
-35% -$473K 0.01% 544
2022
Q3 		$607K Buy
+108,800
New +$532K 0.01% 751
2022
Q1 		$420K Sell
76,200
-2,400
-3% -$14.9K ﹤0.01% 900
2021
Q4 		$670 Buy
78,600
+4,600
+6% +$38K ﹤0.01% 772
2021
Q3 		$643K Buy
74,000
+50,400
+214% +$455K 0.01% 744
2021
Q2 		$249K Sell
23,600
-3,300
-12% -$46.1K ﹤0.01% 960
2021
Q1 		$431K Sell
26,900
-5,000
-16% -$132K ﹤0.01% 906
2020
Q4 		$1.47M Buy
31,900
+22,500
+239% +$1.04M 0.02% 478
2020
Q3 		$331K Buy
+9,400
New +$283K ﹤0.01% 901

Other funds holding IMVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Virginia Retirement Systems's IMVT Position: Q2 2023 in Review

Virginia Retirement Systems sold out of Immunovant (IMVT) in Q2 2023, closing a stake of 19,000 shares — an estimated $295K sold.

Virginia Retirement Systems first reported a position in IMVT in Q3 2020 and held it in 10 quarters. The position peaked at $1.47M in Q4 2020. 147 funds tracked by Wall St. Rank hold IMVT as of Q2 2023.

  • Virginia Retirement Systems reported no remaining Immunovant position as of Q2 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 19,000 Immunovant shares in Q2 2023, an estimated $295K.
  • Virginia Retirement Systems first reported a position in Immunovant in Q3 2020 and held it in 10 quarters.
  • Virginia Retirement Systems's Immunovant position peaked at $1.47M in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Immunovant as of Q2 2023.

Based on Virginia Retirement Systems's 13F filing for Q2 2023, filed 22 Aug 2023.